Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports

The aim of modern insulin therapy used in the treatment of type 1 diabetes mellitus is to mimic the physiological secretion of insulin in order to ensure stable normoglycemia while maintaining the greatest possible comfort of life for diabetic patients. New ultra-fast insulin analogs that can be adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietrzak, Iwona, Szadkowska, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Case report | Opis przypadku
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226363/
https://www.ncbi.nlm.nih.gov/pubmed/35114772
http://dx.doi.org/10.5114/pedm.2022.112621
_version_ 1785050563432415232
author Pietrzak, Iwona
Szadkowska, Agnieszka
author_facet Pietrzak, Iwona
Szadkowska, Agnieszka
author_sort Pietrzak, Iwona
collection PubMed
description The aim of modern insulin therapy used in the treatment of type 1 diabetes mellitus is to mimic the physiological secretion of insulin in order to ensure stable normoglycemia while maintaining the greatest possible comfort of life for diabetic patients. New ultra-fast insulin analogs that can be administered immediately before a meal contribute to the improvement of postprandial glycemia and the quality of life of patients. We presented two cases illustrating the effectiveness and safety of the use of an ultra-fast-acting insulin analog in the treatment of postprandial hyperglycemia in children with type 1 diabetes.
format Online
Article
Text
id pubmed-10226363
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-102263632023-06-05 Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports Pietrzak, Iwona Szadkowska, Agnieszka Pediatr Endocrinol Diabetes Metab Case report | Opis przypadku The aim of modern insulin therapy used in the treatment of type 1 diabetes mellitus is to mimic the physiological secretion of insulin in order to ensure stable normoglycemia while maintaining the greatest possible comfort of life for diabetic patients. New ultra-fast insulin analogs that can be administered immediately before a meal contribute to the improvement of postprandial glycemia and the quality of life of patients. We presented two cases illustrating the effectiveness and safety of the use of an ultra-fast-acting insulin analog in the treatment of postprandial hyperglycemia in children with type 1 diabetes. Termedia Publishing House 2021-12-30 2021-12 /pmc/articles/PMC10226363/ /pubmed/35114772 http://dx.doi.org/10.5114/pedm.2022.112621 Text en Copyright © Polish Society of Pediatric Endocrinology and Diabetes https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), allowing third parties to download and share its works but not commercially purposes or to create derivative works.
spellingShingle Case report | Opis przypadku
Pietrzak, Iwona
Szadkowska, Agnieszka
Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
title Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
title_full Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
title_fullStr Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
title_full_unstemmed Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
title_short Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
title_sort ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports
topic Case report | Opis przypadku
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226363/
https://www.ncbi.nlm.nih.gov/pubmed/35114772
http://dx.doi.org/10.5114/pedm.2022.112621
work_keys_str_mv AT pietrzakiwona ultrafastactinginsulinanaloganewwaytopreventpostprandialhyperglycemiaandimprovequalityoflifeintype1diabetespatientscasereports
AT szadkowskaagnieszka ultrafastactinginsulinanaloganewwaytopreventpostprandialhyperglycemiaandimprovequalityoflifeintype1diabetespatientscasereports

Ejemplares similares